COVID-19’s Impact on Telemedicine: Benefits and Limitations


NeurologyLive compiled a number of interviews and conversations with leaders within the neurology community to discuss how the COVID-19 pandemic has affected telemedicine.

As the 2020 calendar year concludes, NeurologyLive took the time to look back and reflect on how COVID-19 and the pandemic itself has impacted clinical care across a range of different conditions and treatment strategies. The first segment of “Reflections on the Impact of COVID-19: A Short Expert Series,” covers the accelerated use of telemedicine and technology, which served as a vital tool to clinicians throughout the year.

Though the integration of telemedicine had already been in the works prior to the pandemic, a lack of in-person visits and limitations and restrictions on travel forced clinicians to adapt even more.

There are a multitude of pros and cons from the use of telemedicine. On the plus side, incorporating virtual visits into the regular care of certain patient groups can offer them a safe way to connect with their providers, particularly those who have trouble moving or are at-risk for falls. Earlier on in the pandemic, we spoke with Howard Fillit, MD, founding executive director and chief science officer, Alzheimer’s Drug Discovery Foundation, who discussed the positives for telemedicine adoption in geriatric patients.

Fillit is not the only clinician who feels this way, though. Reena Mehra, MD, MS, director, Sleep Disorders Research Program, Cleveland Clinic Lerner College of Medicine, sees the potential of virtual visits and diagnosing patients with sleep apnea through telemedicine. In April, she claimed that its impact will be a large part of how clinical care will be handled going forward.

Telemedicine use has been on the rise for years but its widespread adoption has often been marred by challenges with insurance coverage. Jessica Ailani, MD, FAHS, director, MedStar Georgetown Headache Center, echoed these thoughts in a previous interview, as well as discussed how she addressed the headache community about the approach to headache treatment amid a pandemic. She claimed that this year serves as an example as to why telemedicine is likely to stay.

There are limitations and negatives associated with telemedicine. Our discussion with Jeremy Payne, MD, PhD, director, Stroke Center, Banner-University Medicine Neuroscience Institute, detailed some of the reasons for the lack of progress for telestroke care. He too noted payment issues, particularly from factors such as reimbursement and HIPAA compliance, as part of the problem.

A major aspect that has been hindered throughout the pandemic is the patient-clinician relationship, particularly for clinicians who are seeing a patient for the first time. “You cannot compensate Zoom over that face-to-face interaction. You don’t get to know the person as well when you’re not in the room with them,” Pavel Klein, MD, director, Mid-Atlantic Epilepsy and Sleep Center, in Bethesda, Maryland, told NeurologyLive in October.

Adapting to telemedicine was not easy for either clinicians or their patients. There were a number of adjustments that needed to be made on both sides for clinical care to continue to run smoothly. Jennifer Robblee, MD, neurologist, Jan and Tom Lewis Migraine Treatment Program, and assistant professor of neurology, Barrow Neurological Institute, detailed how she got patient buy-in for telemedicine visits and how to troubleshoot the challenges that were presented.

Looking to 2021, the use of telemedicine could still play a major factor, due to the fact that there are still a large number of daily COVID-19 cases, along with consideration of the time that it will take to evenly distribute the vaccine throughout the country.

Follow the links below to read and watch a few of our telemedicine-based interviews with clinicians from throughout the year.

READ MORE: Adapting Telemedicine for Dementia During COVID-19

WATCH NOW: Barry J. Byrne, MD, PhD: The Long-Term Impact of COVID-19 on Telemedicine

WATCH NOW: Jennifer Robblee, MD: The Influence of Telemedicine and Social Media on Medicine

Related Videos
Emma Ciafaloni, MD, an expert on Duchenne muscular dystrophy
Emma Ciafaloni, MD, an expert on Duchenne muscular dystrophy
Charbel Moussa, MBBS, PhD
4 KOLs are featured in this series.
4 KOLs are featured in this series.
4 KOLs are featured in this series.
5 KOLs are featured in this series.
© 2024 MJH Life Sciences

All rights reserved.